New WHO Guidelines on Person centred monitoring

Slides:



Advertisements
Similar presentations
Standard 6: Clinical Handover
Advertisements

John Aberle-Grasse CDC GAP Strategies for Building National-Scale Longitudinal Patient Monitoring Systems for HIV Treatment and Care Lusaka, October 2-5,
The Implementation of the WHO Asia Pacific Treatment Metrics Dr. YU, Dongbao WHO Regional Office for the Western Pacific 20 July, 2014 Antiretroviral Treatment.
World Health Organization
HIV Patient ART Monitoring Meeting: International Conference Centre, Geneva March 2004 Defining the variables.
Components of HIV/AIDS Case Surveillance: Case Report Forms and Sources.
Orientation on HIV care and ART Recording and Reporting System.
Challenges in monitoring ARV therapy A clinical and public health view of the issues involved Charlie Gilks SRM team, HIV department.
Strategic Information for Anti-RetroViral Treatment Programmes Workshop WHO and UNAIDS Geneva June 30- July
The WHO HIV Drug Resistance Strategy Presented by Dr. Don Sutherland Prepared by: Dr. Don Sutherland Dr Silvia Bertagnolio Dr Diane Bennett HIV Drug Resistance.
HIV/AIDS Track Session. Key Points Application of international reference price list during a national tender is a valuable tool for achieving optimal.
Consultant Advance Research Team. Outline UNDERSTANDING M&E DATA NEEDS PEOPLE, PARTNERSHIP AND PLANNING 1.Organizational structures with HIV M&E functions.
IMPROVING THE HIV, SEXUAL & REPRODUCTIVE HEALTH OF SEX WORKERS TURNING GOOD POLICY INTO GOOD PRACTICE Module 5: Measuring Outcomes.
STRATEGIC INFORMATION FOR ACTION IN VIET NAM 6 th Viet Nam National Scientific Conference 24 November 2015 Ha Noi, Viet Nam Amitabh Bipin SUTHAR, PharmD,
Strengthening Integration between RMNCH and HIV services Nuhu Yaqub WHO Tanzania.
From Aggregate Indicators to Impacting Patients - Data Use to Inform Treatment and Improve Care Ian Wanyeki Track 1.0 Implementers Meeting Dar Es Salaam.
Expert Patients and AIDS Ministry of HealthMSF-OCB Mozambique CDC From Field Operational Research to National Roll Out of CASG in Mozambique.
Improving health worldwide Implications for Monitoring of the HIV Care Cascade? Jim Todd MeSH Satellite Session IAS Durban, Monday 18 th.
What Will it Take to Reach the Fast Track Prevention Targets? July 18, 2016, International AIDS Conference Karl L. Dehne, Chief Prevention, UNAIDS.
Differentiated Monitoring & Evaluation
How differentiated care supports “Tx all” and Dr
Virginia Macdonald, Annette Verster
Contents Global impact 2.Service cascade 3. Policies and WHO support.
TITLE Differentiated Care for People who inject Drugs, Men who have sex with men, Sex workers, Transgender people, Prisoners and other people living in.
Monitoring and Evaluation: A Review of Terms
iCCM Recommended Indicators
Monitoring and Evaluation Frameworks
Zimbabwe’s shift towards treat all: national country context
11 viii. Develop capacity for signal detection and causality assessment Multi-partner training package on active TB drug safety monitoring and management.
Effective HIV & SRH Responses among Key Populations in Myanmar
iCCM Experience Malawi
Using programme M&E data for Surveillance in Nepal: Challenges and Opportunities Name of Author(s): Biwesh Ojha(1)
USAID SHIFT YEAR1 Technical Strategies and Priority TA
Utilizing research as an opportunity to strengthen
A COLLABORATIVE APPROACH TO ESTABLISH PREDICTORS
Achieving World-Class Cancer Outcomes A Strategy for England
Chloe Orkin British HIV Association Queen Mary University London
Achieving World-Class Cancer Outcomes A Strategy for England
The role of CD4 in patient monitoring Amsterdam July 2018
Outline Session 7:00 FRSA0701 Welcome and introductions : WHO general approach to cascade analysis framework : From Cascade Analysis to Action  Jesus M.
The Cost of Differentiated Service Delivery: A Systematic Review
Community patient tracking by Lay Community Health Workers (CHWs) is an effective strategy towards the 2nd & 3rd 90 Morapedi Boitumelo M.
Achieving World-Class Cancer Outcomes A Strategy for England
Achieving World-Class Cancer Outcomes A Strategy for England
The role of the community in TB control
28th November 2016 – First Meeting
From toward HIV Elimination with Boosted-Integrated Active HIV Case Management (B-IACM) in Cambodia Dr. Penh Sun LY, Director, NCHADS Presented.
Christine Halleux, MD, PhD
Achieving World-Class Cancer Outcomes A Strategy for England
How do we progress the multi-sectoral nutrition agenda in Sudan?
Achieving World-Class Cancer Outcomes A Strategy for England
Retention: What It Means for You
HIV CASE BASED SURVEILLANCE IN KENYA
National Cancer Center
monitoring & evaluation THD Unit, Stop TB department WHO Geneva
11 iii. Define management and supervision roles and responsibilities
Contents Global impact 2.Service cascade 3. Policies and WHO support.
The STOP TB Strategy – 2009 VISION: A TB-free world
Indicators, Data Sources and Data Quality for TB M&E
Fabio Scano IUATLD Conference Paris, 2003
Dan Kajungu, PhD, Collins Gyezaho, Davis Natukwatsa.
Monitoring and Evaluation: A Review of Terms
Illustrative Cluster Detection and Response Strategy
The Global Fund Grants January 2018 to March 2021
KATUREEBE CORDELIA, MBchB, MMED Pead
Stakeholder engagement and research utilization: Insights from Namibia
Update on global progress in ART
TB eHealth System for Improved Service Delivery
How are programmes specifically designed using collected data?
Introduction and current status of viral load access
Presentation transcript:

New WHO Guidelines on Person centred monitoring New WHO Guidelines on Person centred monitoring Daniel Low-Beer, WHO 2017 Paris, July 2017

Contents Strengthening and securing person centred data Fifteen key recommendations How to implement the guidelines

Data is part of the package of the primary HIV response: at all levels for decision making Global impact: measure and manage programs Impact surveys Epi and impact reviews: regular, practical evaluation District and facility: focus and differentiation Standard dashboards: testing, treatment, viral load Individual and community: linkage, retention, quality of care 60% of decisions which affect HIV Benefits and tackle security of data Countries that achieve impact use data differently: Thailand, Uganda, Brazil, Malawi, Zimbabwe, Kenya, compared to those that have not

Needs of local health facility Adherence support – ‘When we follow up patients lost to follow up as many as 75% have gone to another clinic, we need to phone up, find them. In terms of time and cost, what took two days can take four or five hours, we can save 50% of our time, we also can’t distinguish new and old patients” (Kuwadzana clinic, Zimbabwe) Drug and Diagnostics - “If they want to come and collect new drugs, they will just get tested again elsewhere. There is retesting, viral load, a new care booklet, follow up every month for six months. We also don’t pick up if they were defaulters. Someone is given first line when they were already on second line. Our forecasting will be more accurate, we can improve stocks by 20%” Differentiated care and people living with HIV – patients who move between clinics, and between community and clinic, receiving HIV and health services. Need a person centred monitoring system to deliver person centred healthcare.

2. New guidelines: strengthen person centred monitoring Strengthen and secure individual basis of M&E systems

Strengthen and secure data for HIV cascade of services 1. 2. 3.

15 key recommendations Minimum dataset for patient care – guidance on standard data set Transitioning to “treat all” – guidance on updated cards, registers, reports transition Simplification of tools – generic tools for adaptation for paper and electronic systems Integration and linkages – generic patient card and link to health folder or passport Data quality review and for quality of care – guidance on annual monitoring review Standardisation of sentinel events and indicators – core information on a standardisation set of sentinel events, a minimum of six, of value for routine care and reporting De-duplication of records to support facilities and improve data – HIV case surveillance should provide de-duplicated counts of diagnosis, treatment and retention to facilities Country situation analysis – tool for country situation analysis for improvements HIV diagnosis and building on patient monitoring – consolidate from diagnosis, treatment to viral suppression. Provides guidance on HIV case definitions Key population data – confidentiality and security are paramount. In most settings patient monitoring should not include KP category, guidance on issues around KP data

15 key recommendations (continued) Promote and use unique identifiers with anonymous codes for sharing of data within and across the national HIV and health programme Transition progressively from paper to electronic information systems – countries should used a tiered approach for transition starting with high volume sites Strengthen and establish different data security levels – differentiate security levels for data elements and invest in robust databases and policies to strengthen security Invest in data systems and ensure interoperability – strengthen investments and security of data systems, with recommended 5-10% of program budget on M&E Use individual data to improve programmes and long term chronic health care Strengthen retention and transfer by sharing information between clinics Ensure linkage by supporting routine sharing between testing, treatment, lab, pharmacy and other health service programs Strengthen integration with long-term chronic health care by using unique identifiers Invest in data analyst capacity: central and district analysis team and routine, simple dashboards to feed back data in real time for programme improvement

Conclusions – the data 90s Global Impact – 90% of fast track programs evaluated causatively for impact on incidence and mortality, using data and some modeling District: 90% of countries have routine, real time district data on testing, treatment and viral load with analyst capacity to feed back to programs Individual M&E: 90% of patients covered by robust, secure patient monitoring and case surveillance from testing to outcomes Combination prevention, care and data is primary public health package